EDITORIAL

 

  Accueil Events Editorial Drug Disposition meetings Careers

  Previous edito's ....      

 

Dear all,

On a regular basis I can notice on the http://stat.biomodels-group.com/ website a significant increase of the daily visits. It seems to correlate nicely with the update of the “edito” and articles related to ex vivo models (mainly IPRL) used in experimental surgery [Mainly about UW or other buffer to improve the preservation of livers]. In order to confirm my initial speculation, I would be grateful if you could share your feedback with me at the following email address: gires.pierre@orange.fr

Many thanks in advance for your cooperation.

Best regards.

Pierre.

 

_______________________________________________________________________________________________

Liver Transpl. 2010 Feb;16(2):163-71.

Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.

Ben Mosbah I, Roselló-Catafau J, Alfany-Fernandez I, Rimola A, Parellada PP, Mitjavila MT, Lojek A, Ben Abdennebi H, Boillot O, Rodés J, Peralta C.

Department of Experimental Pathology Department, Instituto de Investigaciones Biomédicas de Barcelona, CSIC, 08036 Barcelona, Spain.

Abstract

Here we examine the effect of adding carvedilol (CVD) to University of Wisconsin (UW) solution on the preservation of steatotic and nonsteatotic livers during cold ischemia and after normothermic reperfusion. We used an isolated perfused rat liver model. The following protocols were evaluated. Protocol 1 concerned the effect of CVD after cold ischemia. Steatotic and nonsteatotic livers were preserved for 24 hours in UW solution alone or with CVD. Livers without cold ischemia were used as controls. Transaminases were evaluated in the flushing effluent. Protocol 2 involved the effect of CVD after reperfusion. Both liver types were preserved for 24 hours in UW solution alone or with CVD and then perfused ex vivo for 2 hours at 37 degrees C. Livers flushed and perfused without ischemia were used as controls. Hepatic injury and functionality [transaminases, bile production, and hepatic clearance of sulfobromophthalein (BSP)] were evaluated after reperfusion. In addition, factors potentially involved in hepatic ischemia-reperfusion injury, including oxidative stress (malondialdehyde and superoxide anion levels), mitochondrial damage (glutamate dehydrogenase activity), microcirculatory disorders (flow rate and vascular resistance), and adenosine triphosphate (ATP) depletion, were evaluated after reperfusion. After cold ischemia, steatotic livers preserved in UW solution showed higher transaminase levels than nonsteatotic livers. After reperfusion, steatotic livers preserved in UW solution showed higher transaminase levels and lower bile production and BSP clearance than nonsteatotic livers. Alterations in the perfusion flow rate and vascular resistance, mitochondrial damage, and reduced ATP content were more evident in steatotic livers preserved in UW solution. The addition of CVD to UW solution reduced hepatic injury, obstructed its mechanisms, and improved hepatic functionality in both liver types. We conclude that CVD is a useful additive for UW solution that improves the preservation of steatotic and nonsteatotic livers subjected to prolonged cold ischemia.

PMID: 20104484 [PubMed - indexed for MEDLINE]

Supplemental Content

Click here to read

 

----------------------------------------------------------------------------------------------------------------------------------

 

From 2001

 

Pretreatment with calcitonin gene-related peptide attenuates hepatic ischemia/reperfusion injury in rats.

Effect of gonadectomy on the metabolism of arachidonic acid in isolated kidney of a rat model of metabolic syndrome.

Strategy of predictiion of the first dose ad in man

  Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers

- Multiple mechanisms are involved in the biliary excretion of acetaminophen su. in the rat: role of Mrp2 and Bcrp1.

 Effects of free fatty acids on carbohydrate metabolism and insulin signalling in perfused rat liver.

 Differential involment of  Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat.  

  Membrane transporters and drug absorption: the transporters are there, but how active are they in vivo  ? John Woodley,

 - Isolated Perfused Livers: Application Fields    Pierre Gires

  Wartime tactic and transporters   Jean-Michel SCHERRMANN, PhD  

   - Determination of antiviral nucleoside analogue AM 365 and AM 188 in perfusate and bile of IPRL using HPLC.  Wang J

  - Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay. 

  - Glycogenolysis and inhibits both glycogenesis via gluconeogenesis and from exogenous glucose in perfused rat liver.

  - Perfused Everted Intestinal Segments of Rat  & rat everted gut sacs.

 - Impact of excipient on the absorption of P-glycoprotein substrates in vitro and in vivo. Gilles Cornaire.

- Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats.   Hanafy A, Langguth P, Spahn-Langguth H.

Absorption windows" in the Gastrointestinal Tract: Do they exist.   John Woodley                               

Introduction to invitro models of intestinal barriere Report and Recommendations of ECVAM Workshop

- Hepatic uptake of bromosulfophtalein-glutathion in perfused Eisai hyperbilirubinemic mutant rat liver. Geng W

 

top page